{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T18:37:10Z","timestamp":1771007830907,"version":"3.50.1"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["redjournal.org","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Radiation Oncology*Biology*Physics"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/j.ijrobp.2018.03.039","type":"journal-article","created":{"date-parts":[[2018,3,31]],"date-time":"2018-03-31T16:37:42Z","timestamp":1522514262000},"page":"593-601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Evaluation of XRCC1 Gene Polymorphism as a Biomarker in Head and Neck Cancer Patients Undergoing Chemoradiation Therapy"],"prefix":"10.1016","volume":"101","author":[{"given":"Sambit Swarup","family":"Nanda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ajeet Kumar","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madhup","family":"Rastogi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rohini","family":"Khurana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahat","family":"Hadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamal","family":"Sahni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Surendra Prasad","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anoop K.","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Madan Lal Brahma","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devendra","family":"Parmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijrobp.2018.03.039_bib1","unstructured":"GLOBOCAN 2012: Estimated cancer incidence, mortality and prevalence worldwide in 2012. Available at: http:\/\/globocan.iarc.fr\/Pages\/fact_sheets_cancer.aspx. Accessed February 15, 2018."},{"key":"10.1016\/j.ijrobp.2018.03.039_bib2","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1200\/JCO.2003.01.008","article-title":"An intergroup phase III comparison of standard radiation therapy and two schedules of concurrent chemoradiotherapy in patients with unresectable squamous cell head and neck cancer","volume":"21","author":"Adelstein","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/S1470-2045(11)70346-1","article-title":"Concomitant chemoradiotherapy versus acceleration of radiotherapy with or without concomitant chemotherapy in locally advanced head and neck carcinoma (GORTEC 99-02): An open-label phase 3 randomised trial","volume":"13","author":"Bourhis","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib4","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1056\/NEJMoa031317","article-title":"Concurrent chemotherapy and radiotherapy for organ preservation in advanced laryngeal cancer","volume":"349","author":"Forastiere","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib5","doi-asserted-by":"crossref","first-page":"10798","DOI":"10.1038\/srep10798","article-title":"Induction chemotherapy with concurrent chemoradiotherapy versus concurrent chemoradiotherapy for locally advanced squamous cell carcinoma of head and neck: A meta-analysis","volume":"5","author":"Zhang","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/02841860310004364","article-title":"Cisplatin and radiotherapy in the treatment of locally advanced head and neck cancer\u2014A review of their cooperation","volume":"42","author":"Marcu","year":"2009","journal-title":"Acta Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.radonc.2010.07.018","article-title":"Searching for genetic determinants of normal tissue radiosensitivity\u2014Are we on the right track?","volume":"97","author":"Andreassen","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib8","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1002\/ijc.22981","article-title":"In\u00a0vitro radiation-induced expression of XPC mRNA as a possible biomarker for developing adverse reactions during radiotherapy","volume":"121","author":"Wiebalk","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib9","doi-asserted-by":"crossref","first-page":"4802","DOI":"10.1158\/1078-0432.CCR-04-2657","article-title":"Association between polymorphisms in the DNA repair genes, XRCC1, APE1, and XPD and acute side effects of radiotherapy in breast cancer patients","volume":"11","author":"Chang-Claude","year":"2005","journal-title":"Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib10","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ijrobp.2010.04.023","article-title":"Association between genetic polymorphisms in the XRCC1, XRCC3, XPD, GSTM1, GSTT1, MSH2, MLH1, MSH3, and MGMT genes and radiosensitivity in breast cancer patients","volume":"81","author":"Mangoni","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib11","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.canrad.2008.07.009","article-title":"Radiation-induced sequelae: Toward an individual profile","volume":"12","author":"Azria","year":"2008","journal-title":"Cancer Radiother"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib12","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/j.semradonc.2007.10.004","article-title":"Genetic markers for prediction of normal tissue toxicity after radiotherapy","volume":"18","author":"Alsner","year":"2008","journal-title":"Semin Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib13","doi-asserted-by":"crossref","first-page":"e89079","DOI":"10.1371\/journal.pone.0089079","article-title":"Polymorphisms in radio-responsive genes and its association with acute toxicity among head and neck cancer patients","volume":"9","author":"Venkatesh","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib14","doi-asserted-by":"crossref","first-page":"4333","DOI":"10.1200\/JCO.2006.05.8768","article-title":"DNA-repair gene polymorphisms predict favorable clinical outcome among patients with advanced squamous cell carcinoma of the head and neck treated with cisplatin-based induction chemotherapy","volume":"24","author":"Quintela-Fandino","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib15","doi-asserted-by":"crossref","first-page":"12446","DOI":"10.4238\/2015.October.16.11","article-title":"Prognostic significance of head and neck squamous cell carcinoma repair gene polymorphism","volume":"14","author":"Stur","year":"2015","journal-title":"Genet Mol Res"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib16","series-title":"AJCC Cancer Staging Manual","year":"2010"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib17","series-title":"Prescribing, Recording, and Reporting Photon Beam Therapy (Report 50)","year":"1993"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib18","series-title":"Prescribing, Recording, and Reporting Photon Beam Therapy (Report 62) (Supplement to ICRU Report 50)","year":"1999"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib19","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/0360-3016(95)00060-C","article-title":"Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)","volume":"31","author":"Cox","year":"1995","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib20","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1002\/1097-0142(19810101)47:1<207::AID-CNCR2820470134>3.0.CO;2-6","article-title":"Reporting results of cancer treatment","volume":"47","author":"Miller","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib21","doi-asserted-by":"crossref","first-page":"6530","DOI":"10.1093\/emboj\/20.22.6530","article-title":"XRCC1 coordinates the initial and late stages of DNA abasic site repair through protein-protein interactions","volume":"20","author":"Vidal","year":"2001","journal-title":"EMBO J"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib22","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.radonc.2010.01.016","article-title":"Association of single nucleotide polymorphisms in ATM, GSTP1, SOD2, TGFB1, XPD and XRCC1 with clinical and cellular radiosensitivity","volume":"97","author":"Zschenker","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib23","first-page":"604","article-title":"Nonconservative amino acid substitution variants exist at polymorphic frequency in DNA repair genes in healthy humans","volume":"58","author":"Shen","year":"1998","journal-title":"Cancer Res"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib24","doi-asserted-by":"crossref","first-page":"379","DOI":"10.3109\/13547501003797664","article-title":"Polymorphisms in DNA damage response genes and head and neck cancer risk","volume":"15","author":"Flores-Obando","year":"2010","journal-title":"Biomarkers"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/BF03032401","article-title":"Polymorphisms of the XRCC1 DNA repair gene in head and neck cancer","volume":"11","author":"Demokan","year":"2005","journal-title":"Pathol Oncol Res"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib26","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1756-9966-28-37","article-title":"Genetic polymorphisms in DNA base excision repair gene XRCC1 and the risk of squamous cell carcinoma of the head and neck","volume":"28","author":"Kowalski","year":"2009","journal-title":"J Exp Clin Cancer Res"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib27","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1002\/ijc.22547","article-title":"Polymorphisms at XPD and XRCC1 DNA repair loci and increased risk of oral leukoplakia and cancer among NAT2 slow acetylators","volume":"120","author":"Majumder","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib28","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.oraloncology.2005.08.010","article-title":"Single nucleotide polymorphisms of DNA repair genes XRCC1 and XPD and its molecular mapping in Indian oral cancer","volume":"42","author":"Ramachandran","year":"2006","journal-title":"Oral Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib29","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1002\/ijc.20338","article-title":"Association of DNA repair gene XRCC1 polymorphisms with head and neck cancer in Korean population","volume":"111","author":"Tae","year":"2004","journal-title":"Int J Cancer"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1600-0714.2007.00608.x","article-title":"Combinational polymorphisms of four DNA repair genes XRCC1, XRCC2, XRCC3, and XRCC4 and their association with oral cancer in Taiwan","volume":"37","author":"Yen","year":"2008","journal-title":"J Oral Pathol Med"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib31","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1093\/carcin\/22.6.917","article-title":"Amino acid substitution variants of APE1 and XRCC1 genes associated with ionizing radiation sensitivity","volume":"22","author":"Hu","year":"2001","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib32","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1002\/em.10058","article-title":"Genetic regulation of ionizing radiation sensitivity and breast cancer risk","volume":"39","author":"Hu","year":"2002","journal-title":"Environ Mol Mutagen"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib33","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.1289\/ehp.6632","article-title":"Functional characterization of polymorphisms in DNA repair genes using cytogenetic challenge assays","volume":"111","author":"Au","year":"2003","journal-title":"Environ Health Perspect"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib34","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/1748-717X-8-31","article-title":"XRCC1 codon 399Gln polymorphism is associated with radiotherapy-induced acute dermatitis and mucositis in nasopharyngeal carcinoma patients","volume":"8","author":"Li","year":"2013","journal-title":"Radiat Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib35","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.radonc.2011.05.062","article-title":"Association between single nucleotide polymorphisms in the XRCC1 and RAD51 genes and clinical radiosensitivity in head and neck cancer","volume":"99","author":"Pratesi","year":"2011","journal-title":"Radiother Oncol"},{"issue":"Suppl. 1","key":"10.1016\/j.ijrobp.2018.03.039_bib36","doi-asserted-by":"crossref","first-page":"S24","DOI":"10.1016\/S0167-8140(11)70053-6","article-title":"Association between genetic polymorphisms in the xrcc1, xrcc3, rad51 and gstp1 genes and clinical radiosensitivity in head and neck cancer patients","volume":"98","author":"Paiar","year":"2011","journal-title":"Radiother Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib37","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1097\/JTO.0b013e318031cd89","article-title":"A pharmacogenomic study of docetaxel and gemcitabine for the initial treatment of advanced non-small cell lung cancer","volume":"2","author":"Petty","year":"2007","journal-title":"J Thorac Oncol"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib38","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.lungcan.2008.02.019","article-title":"XRCC1 polymorphisms and severe toxicity in lung cancer patients treated with cisplatin-based chemotherapy in Chinese population","volume":"62","author":"Wang","year":"2008","journal-title":"Lung Cancer"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib39","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/j.ijrobp.2005.07.951","article-title":"The polymorphism and haplotypes of XRCC1 and survival of non-small-cell lung cancer after radiotherapy","volume":"63","author":"Yoon","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib40","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.1007\/s00405-015-3740-4","article-title":"Influence of allelic variations of hypoxia-related and DNA repair genes on patient outcome and toxicity in head and neck cancer treated with radiotherapy plus cetuximab","volume":"273","author":"Mu\u00f1oz","year":"2016","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/j.ijrobp.2018.03.039_bib41","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1002\/ijc.28847","article-title":"Treatment de-escalation in HPV-positive oropharyngeal carcinoma: Ongoing trials, critical issues and perspectives","volume":"136","author":"Mirghani","year":"2015","journal-title":"Int J Cancer"}],"container-title":["International Journal of Radiation Oncology*Biology*Physics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161830587X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S036030161830587X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T20:51:31Z","timestamp":1534971091000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S036030161830587X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S036030161830587X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.03.039","relation":{},"ISSN":["0360-3016"],"issn-type":[{"value":"0360-3016","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Evaluation of XRCC1 Gene Polymorphism as a Biomarker in Head and Neck Cancer Patients Undergoing Chemoradiation Therapy","name":"articletitle","label":"Article Title"},{"value":"International Journal of Radiation Oncology*Biology*Physics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijrobp.2018.03.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}